BIOMAT Database Logo BIOMAT Database Logo

The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. 1993

H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Department of Surgery, Massachusetts General Hospital, Boston 02114.

In vitro studies have revealed several pathways by which T cells can respond to alloantigens, including CD4+ direct responses to allogeneic class II antigens, CD8+ direct responses to allogeneic class I antigens, and CD4+ "indirect" responses to peptides of alloantigens presented in association with responder class II molecules. In vivo studies of skin graft rejection, however, have so far provided clear evidence for the contribution of only the two direct pathways and not for indirect recognition. We have used major histocompatibility complex class II-deficient mice as donors to test the role of indirect recognition in rejection of skin grafts. Class II-deficient skin was always rejected without delay by normal recipients. Removal of recipient CD8+ cells (to leave the animals dependent on CD4+ function) or depletion of recipient CD4+ cells revealed that CD4+ cells were usually involved and sometimes absolutely required in this rapid rejection. Since the donor grafts lacked class II antigens, the CD4+ cells must have recognized donor antigens presented in association with recipient class II molecules. These results therefore indicate that indirect recognition can initiate rapid skin graft rejection.

UI MeSH Term Description Entries
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
May 1995, Immunology,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
May 1999, Transplantation,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
June 1992, The Journal of experimental medicine,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
February 1993, Transplantation proceedings,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.
April 1994, The Journal of experimental medicine,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.
September 1991, Science (New York, N.Y.),
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts.
March 1988, Transplantation,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.
October 1995, The Journal of experimental medicine,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.
March 1996, Journal of virology,
H Auchincloss, and R Lee, and S Shea, and J S Markowitz, and M J Grusby, and L H Glimcher
Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice.
October 2000, European journal of immunology,
Copied contents to your clipboard!